全文获取类型
收费全文 | 2054117篇 |
免费 | 151516篇 |
国内免费 | 6099篇 |
专业分类
耳鼻咽喉 | 27530篇 |
儿科学 | 66778篇 |
妇产科学 | 57732篇 |
基础医学 | 298073篇 |
口腔科学 | 56842篇 |
临床医学 | 190885篇 |
内科学 | 400173篇 |
皮肤病学 | 41818篇 |
神经病学 | 168682篇 |
特种医学 | 77473篇 |
外国民族医学 | 671篇 |
外科学 | 299635篇 |
综合类 | 44831篇 |
现状与发展 | 1篇 |
一般理论 | 695篇 |
预防医学 | 167218篇 |
眼科学 | 45989篇 |
药学 | 149650篇 |
9篇 | |
中国医学 | 4564篇 |
肿瘤学 | 112483篇 |
出版年
2019年 | 16529篇 |
2018年 | 23175篇 |
2017年 | 17756篇 |
2016年 | 19259篇 |
2015年 | 21923篇 |
2014年 | 30531篇 |
2013年 | 47309篇 |
2012年 | 64423篇 |
2011年 | 68622篇 |
2010年 | 40402篇 |
2009年 | 37577篇 |
2008年 | 63528篇 |
2007年 | 67239篇 |
2006年 | 67489篇 |
2005年 | 65547篇 |
2004年 | 62637篇 |
2003年 | 60022篇 |
2002年 | 58602篇 |
2001年 | 91460篇 |
2000年 | 94127篇 |
1999年 | 79523篇 |
1998年 | 22632篇 |
1997年 | 20585篇 |
1996年 | 20301篇 |
1995年 | 19167篇 |
1994年 | 18053篇 |
1993年 | 17057篇 |
1992年 | 63230篇 |
1991年 | 61557篇 |
1990年 | 59830篇 |
1989年 | 57183篇 |
1988年 | 53068篇 |
1987年 | 51957篇 |
1986年 | 49593篇 |
1985年 | 47493篇 |
1984年 | 35818篇 |
1983年 | 30464篇 |
1982年 | 18440篇 |
1979年 | 32721篇 |
1978年 | 23181篇 |
1977年 | 19269篇 |
1976年 | 18722篇 |
1975年 | 19616篇 |
1974年 | 23766篇 |
1973年 | 23083篇 |
1972年 | 21546篇 |
1971年 | 20020篇 |
1970年 | 18804篇 |
1969年 | 17374篇 |
1968年 | 16570篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
31.
目的 运用网络药理学方法及分子对接技术探讨黄芪干预腹膜纤维化的可能机制。方法 利用中药系统药理学数据库及分析平台(TCMSP)检索黄芪的主要化学成分及靶点,并补充文献报道相关药理作用的成分作为潜在活性成分。以"peritoneal fibrosis"为关键词分别在OMIM、Genecards获取目前已知的与腹膜纤维化相关的疾病靶点,后取两者的交集靶点;对交集基因通过STRING数据库与Cytoscape 3.7.2软件构建"药物-成分-靶点-疾病"网络及蛋白互作(PPI)网络并筛选核心网络。基于R软件使用Bioconductor生物信息软件对核心靶点进行GO及KEGG富集分析,最终采用AutoDock软件将主要有效成分与核心靶点进行分子对接,得出其结合能力。结果 筛选出20个黄芪活性成分及文献报道有相关药理作用4个, 457药物作用靶点,与674个腹膜纤维化病靶点取交集,得到86个共同靶点。GO功能富集分析提示黄芪拮抗腹膜纤维化主要参与了蛋白激酶B信号转导的调节、细胞对化学的应激反应、炎症反应的调节等通路; KEGG通路富集分析主要涉及调控肿瘤、磷脂酰肌醇-3-羟激酶-蛋白激酶B(PI3K-Akt)、晚期糖基化终末产物/晚期糖基化终末产物受体(AGE-RAGE)、人类巨细胞病毒感染、HIF-1信号通路等;分子对接结果显示关键靶点与活性成分具有较好的结合能力。结论 黄芪治疗腹膜纤维化的分子机制,可能与抑制炎症及氧化应激反应、调节多种信号通路等相关。 相似文献
32.
33.
34.
Brittney H. Cotta Margaret F. Meagher Aaron Bradshaw Stephen T. Ryan Gerant Rivera-Sanfeliz 《Expert review of anticancer therapy》2019,19(4):301-308
Introduction: Percutaneous renal mass biopsy has evolved over the last decade with improvements on previous pitfalls including low tissue yield, high non-diagnostic rates, and complications. As understanding of tumor biology and natural history of renal cortical neoplasms has improved, percutaneous renal mass biopsy is poised to have an expanding role in an area characterized by individualized management and refined risk stratification.
Areas covered: This review summarizes the evolution of renal mass biopsy to its current state with respect to outcomes, indications, and clinical guidelines.
Expert opinion: With improved understanding of differential biological potential of renal cortical neoplasms combined with technical improvements in diagnostic yield and accuracy, utilization of renal mass biopsy is becoming an important adjunct to patient care in a broad range of clinical scenarios, including active surveillance, thermal ablation, and use of primary systemic therapy in localized and advanced settings. 相似文献
35.
36.
37.
38.
Breanne E. Kunstler Jill L. Cook Joanne L. Kemp Paul D. O’Halloran Caroline F. Finch 《Journal of Science and Medicine in Sport》2019,22(1):2-10
Objectives
To determine: (i) the behaviour change techniques used by a sample of Australian physiotherapists to promote non-treatment physical activity; and (ii) whether those behaviour change techniques are different to the techniques used to encourage adherence to rehabilitation exercises.Design
Cross-sectional survey.Method
An online self-report survey was advertised to private practice and outpatient physiotherapists treating patients with musculoskeletal conditions. The use of 50 behaviour change techniques were measured using five-point Likert-type scale questions.Results
Four-hundred and eighty-six physiotherapists responded to the survey, with 216 surveys fully completed. Most respondents (85.1%) promoted non-treatment physical activity often or all of the time. Respondents frequently used 29 behaviour change techniques to promote non-treatment physical activity or encourage adherence to rehabilitation exercises. A similar number of behaviour change techniques was frequently used to encourage adherence to rehabilitation exercises (n = 28) and promote non-treatment physical activity (n = 26). Half of the behaviour change techniques included in the survey were frequently used for both promoting non-treatment physical activity and encouraging adherence to rehabilitation exercises (n = 25). Graded tasks was the most, and punishment was the least, frequently reported technique used to promote non-treatment physical activity and encourage adherence to rehabilitation exercises.Conclusions
Respondents reported using similar behaviour change techniques to promote non-treatment physical activity and encourage adherence to rehabilitation exercises. The variability in behaviour change technique use suggests the behaviour the physiotherapist is promoting influences their behaviour change technique choice. Including the frequently-used behaviour change techniques in non-treatment physical activity promotion interventions might improve their efficacy. 相似文献39.
Platelets are needed to prevent or arrest bleeding and aggregate at the site of injury upon vascular damage. Platelets express receptors for estrogens which might affect the function of the platelets and their hemostatic ability. The aim was to identify possible differences in platelet function related to age, gender, and phases of the menstrual cycle by use of impedance aggregometry with Multiplate. In the first part of the study, platelet function was assessed in 60 healthy individuals (30 men and 30 women) in each of three age groups (20–25, 40–45, and 60–65 years). In the second part of the study, the platelet function was analyzed on four occasions during the menstrual cycle in women without oral contraceptives (OCs) (n = 17) and compared to 19 women on OCs and 18 men of similar age (20–40 years). For the women on OCs, aggregation was analyzed once during the tablet-free week and once late during the period with OCs. The men were sampled once. Women of younger age (<45 years) had significantly higher agonist-induced aggregation response than both men and post-menopausal women (60–65 years). The agonist-induced aggregation response did not differ between phases of the menstrual cycle or OC use. The results suggest that estradiol and/or progesterone affect spontaneous aggregation since it was found to be lowest in the mid-luteal phase. Spontaneous aggregation was significantly lower in women on OCs than in both men and women without OCs. Our findings indicate that fertile age is associated with higher aggregation response capacity of the platelets, possibly to prevent excessive bleeding during menstruation, but this response capacity is not altered during the menstrual cycle or by use of OCs. 相似文献
40.